We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Moderna has signed a 10-year agreement with Swiss manufacturer Lonza to manufacture its COVID-19 vaccine candidate and other future products. Read More
Gilead announced that it has 1.5 million individual doses of its antiviral remdesivir available for use as a COVID-19 treatment and will donate the doses when they’re needed. Read More
Vertex Pharmaceuticals’ cystic fibrosis drug Trikafta (elexacaftor/tezacaftor/ivacaftor) will need a dramatic price cut to be cost effective, the Institute for Clinical and Economic Review (ICER) found in a new analysis. Read More
Drugmakers are reporting shortages of two drugs needed for ventilator patients as demand increases due to COVID-19, propofol and dexmedetomidine. Read More